Intrinsic Value of S&P & Nasdaq Contact Us

SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$62.50
+33%

SpringWorks Therapeutics, Inc. (SWTX) reported total assets of $505.36M and total liabilities of $87.96M for quarter ending 2025-03-31, resulting in total equity of $0.00.

The company held $287.87M in cash and short-term investments. Total debt stood at $7.39M, with net debt of $-56.38M.

Current ratio is 4.33, indicating strong short-term liquidity. Interest coverage is -80.7x (weak).

Criteria supported by this page:

  • HEALTH (100/100, Pass) — Debt-to-Equity of ?, current ratio of 4.33, interest coverage -80.7x — balance sheet is strong
  • MOAT (70/100) — Total assets $505.36M and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 57/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
57/100
SG Score
View full scorecard →
VALUE
90/100
Price-to-Earnings & upside
→ Valuation
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
70/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
SpringWorks Therapeutics, Inc. Balance Sheet History
Metric Q1 FY2025 Q4 FY2024 Q3 FY2024 Q2 FY2024
Total Assets $505.36M$587.28M$608.88M$617.33M
Total Liabilities $87.96M$106.17M$76.3M$60.6M
Total Debt $7.39M$7.91M$6.91M$7.06M
Cash & Investments $287.87M$307.99M$376.62M$383.89M
Total Stockholders Equity $417.4M$481.1M$532.58M$556.73M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message